Norway vs United States of America: Proportion of isolates with decreased susceptibility or resistance
Norway
0
in 2018
United States of America
0.2907
in 2018
Norway rank
15th
United States of America rank
14th
Proportion of isolates with decreased susceptibility or resistance over time
- Norway
- United States of America
How they compare
United States of America currently reports 0.2907 against 0 in Norway, a difference of 0.2907.
The two have swapped places 1 time across 10 shared years of data; in 2009 it was Norway ahead.
Norway ranks 15th and United States of America ranks 14th of 27 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.9091 | 0.7993 | 0.1098 | Norway |
| 2010s | 2.98 | 0.3382 | 2.64 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Norway or United States of America?
- United States of America, at 0.2907 against 0 in Norway as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Norway and United States of America?
- 0.2907, with United States of America ahead.
- How many years of comparable data are there for Norway and United States of America?
- 10 years are reported by both, from 2009 to 2018.
- How do Norway and United States of America rank globally for proportion of isolates with decreased susceptibility or resistance?
- Norway ranks 15th and United States of America ranks 14th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.